The jury determined that the companies knew about the asbestos and failed to warn consumers.

By Julie Mazziotta
June 18, 2019

A California jury decided Wednesday that Johnson & Johnson and Colgate-Palmolive talcum products likely caused a woman’s terminal cancer and awarded her $12 million in damages.

The Alameda County Superior Court jury determined that it was likely that three products — Johnson & Johnson’s baby powder and Shower to Shower products and Colgate’s Cashmere Bouquet — contained asbestos that caused Patricia Schmitz’s.

They determined that the companies knew about the asbestos and failed to warn consumers, and found them guilty of negligence, though the jury could not agree if they acted with “malice, oppression or fraud,” which would entitle Schmitz to punitive damages, Law360 reported.

RELATED: Johnson & Johnson Allegedly Knew Baby Powder Contaminated with Asbestos for Decades

This is the fourth lawsuit against Johnson & Johnson that went in favor of the plaintiff, though five other cases in the last several months found that the company was not responsible for the plantiff’s cancer. There are over 13,000 similar cases awaiting court dates.

Johnson & Johnson said in a statement shared with PEOPLE that they plan to appeal.

“We will pursue an appeal because Johnson’s Baby Powder does not contain asbestos or cause cancer, as supported by decades of independent clinical evidence. There were serious procedural and evidentiary errors in the proceeding that required us to move for mistrial on multiple occasions and we believe provide strong grounds for appeal.”

Justin Sullivan/Getty

RELATED: Can Using Baby Powder Down There Really Cause Cancer? A New Investigation Offers More Clues

Colgate also said that they plan to appeal the ruling, and noted that they discontinued selling the Cashmere Bouquet product in 1995.

“Colgate is disappointed with the jury verdict, which we believe is inconsistent with the facts and evidence presented at trial. This trial suffered from numerous significant legal and evidentiary errors that we believe unfairly prejudiced the defense. Most notably, the testimony of Colgate’s corporate representative was limited so that the jury was not allowed to hear live and complete evidence about Colgate’s extensive and state of the art talc testing program that was recognized by the FDA.”

RELATED: Third Lawsuit Links Ovarian Cancer to Johnson & Johnson Baby Powder

In December, Reuters published an in-depth investigation that found Johnson & Johnson knew its baby powder occasionally tested positive for small amounts of asbestos and allegedly covered up the findings. Their examination of internal company and court documents determined that Johnson & Johnson had known this since 1971, but never shared that information outside of the company. However, the majority of testing did not find asbestos in the talcum products.

Johnson & Johnson said that they believe that Wednesday’s ruling will be reversed on appeal. After a similar ruling in March, when a woman who also has mesothelioma was awarded $29 million by a California jury, they had said the same.

“We will pursue an appeal because Johnson’s Baby Powder does not contain asbestos or cause cancer. We respect the legal process and reiterate that jury verdicts are not medical, scientific or regulatory conclusions about a product. Decades of tests by independent, non-litigation driven experts and institutions repeatedly confirm that Johnson’s Baby Powder does not contain asbestos or cause cancer. We believe these issues will warrant a reversal on appeal.”

To get our top stories delivered to your inbox, sign up for the Healthy Living newsletter

Advertisement